{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:31:24Z","timestamp":1794047484119,"version":"4.8.0"},"reference-count":65,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"2","license":[{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>While T-cell lymphomas are classified as mature neoplasms, emerging evidence indicates that malignant transformation may occur at an earlier stage of T-cell maturation. In this study, we determined clonal architecture in a broad range of T-cell lymphomas. Our multidimensional profiling indicates that many of these lymphomas do in fact emerge from an immature lymphoid T-cell precursor at a maturation stage prior to V(D)J rearrangement that undergoes branching evolution. Consequently, at single-cell resolution we observed considerable clonal tiding under selective therapeutic pressure. T-cell receptor next-generation sequencing suggested a highly biased usage of TRBV20-1 gene segments as part of multiple antigen receptor rearrangements per patient. The predominance of TRBV20-1 was found across all major T-cell lymphoma subtypes analyzed. This suggested that this particular V gene \u2013 independently of complementarity-determining region 3 configuration \u2013 may represent a driver of malignant transformation. Together, our data indicate that T-cell lymphomas are derived from immature lymphoid precursors and display considerable intratumoral heterogeneity that may provide the basis for relapse and resistance in these hard-to-treat cancers.<\/jats:p>","DOI":"10.3324\/haematol.2024.285395","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T01:39:01Z","timestamp":1724895541000},"page":"457-469","source":"Crossref","is-referenced-by-count":8,"title":["T-cell receptor architecture and clonal tiding provide insight into the transformation trajectory of peripheral T-cell lymphomas"],"prefix":"10.3324","volume":"110","author":[{"given":"Edith","family":"Willscher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Schulthei\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Paschold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Lea Sch\u00fcmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Schmidt-Barbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Wickenhauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mascha","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2024,8,29]]},"reference":[{"key":"72278","doi-asserted-by":"crossref","unstructured":"Alaggio R, Amador C, Anagnostopoulos I. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022; 36(7):1720-1748.","DOI":"10.1038\/s41375-022-01625-x"},{"key":"72279","doi-asserted-by":"crossref","unstructured":"Campo E, Jaffe ES, Cook JR. The International Consensus Classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee. Blood. 2022; 140(11):1229-1253.","DOI":"10.1182\/blood.2022015851"},{"key":"72280","doi-asserted-by":"crossref","unstructured":"Fiore D, Cappelli LV, Broccoli A, Zinzani PL, Chan WC, Inghirami G. Peripheral T cell lymphomas: from the bench to the clinic. Nat Rev Cancer. 2020; 20(6):323-342.","DOI":"10.1038\/s41568-020-0247-0"},{"key":"72281","doi-asserted-by":"crossref","unstructured":"Dummer R, Vermeer MH, Scarisbrick JJ. Cutaneous T cell lymphoma. Nat Rev Dis Primers. 2021; 7(1):61.","DOI":"10.1038\/s41572-021-00296-9"},{"key":"72282","doi-asserted-by":"crossref","unstructured":"Hague C, Farquharson N, Menasce L, Parry E, Cowan R. Cutaneous T-cell lymphoma: diagnosing subtypes and the challenges. Br J Hosp Med (Lond). 2022; 83(4):1-7.","DOI":"10.12968\/hmed.2021.0149"},{"key":"72283","doi-asserted-by":"crossref","unstructured":"Park HS, McIntosh L, Braschi-Amirfarzan M, Shinagare AB, Krajewski KM. T-Cell Non-Hodgkin lymphomas: spectrum of disease and the role of imaging in the management of common subtypes. Korean J Radiol. 2017; 18(1):71-83.","DOI":"10.3348\/kjr.2017.18.1.71"},{"key":"72284","doi-asserted-by":"crossref","unstructured":"Broccoli A, Zinzani PL. Peripheral T-cell lymphoma, not otherwise specified. Blood. 2017; 129(9):1103-1112.","DOI":"10.1182\/blood-2016-08-692566"},{"key":"72285","doi-asserted-by":"crossref","unstructured":"Marks DI, Rowntree C. Management of adults with T-cell lymphoblastic leukemia. Blood. 2017; 129(9):1134-1142.","DOI":"10.1182\/blood-2016-07-692608"},{"key":"72286","doi-asserted-by":"crossref","unstructured":"Izykowska K, Rassek K, Korsak D, Przybylski GK. Novel targeted therapies of T cell lymphomas. J Hematol Oncol. 2020; 13(1):176.","DOI":"10.1186\/s13045-020-01006-w"},{"key":"72287","doi-asserted-by":"crossref","unstructured":"Bellei M, Foss FM, Shustov AR. The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project. Haematologica. 2018; 103(7):1191-1197.","DOI":"10.3324\/haematol.2017.186577"},{"key":"72288","doi-asserted-by":"crossref","unstructured":"Chihara D, Fanale MA, Miranda RN. The survival outcome of patients with relapsed\/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma. Br J Haematol. 2017; 176(5):750-758.","DOI":"10.1111\/bjh.14477"},{"key":"72289","doi-asserted-by":"crossref","unstructured":"Lansigan F, Horwitz SM, Pinter-Brown LC. Outcomes for relapsed and refractory peripheral T-cell lymphoma patients after front-line therapy from the COMPLETE registry. Acta Haematol. 2020; 143(1):40-50.","DOI":"10.1159\/000500666"},{"key":"72290","doi-asserted-by":"crossref","unstructured":"Stuver R, Moskowitz AJ. Therapeutic advances in relapsed and refractory peripheral T-cell lymphoma. Cancers (Basel). 2023; 15(3):589.","DOI":"10.3390\/cancers15030589"},{"key":"72291","doi-asserted-by":"crossref","unstructured":"Iyer A, Hennessey D, Gniadecki R. Clonotype pattern in T-cell lymphomas map the cell of origin to immature lymphoid precursors. Blood Adv. 2022; 6(7):2334-2345.","DOI":"10.1182\/bloodadvances.2021005884"},{"key":"72292","doi-asserted-by":"crossref","unstructured":"Marks JA, Switchenko JM, Martini DJ. T-cell receptor gene rearrangement clonality, flow cytometry status, and associated outcomes in early-stage cutaneous T-cell lymphoma. JAMA Dermatol. 2021; 157(8):954-962.","DOI":"10.1001\/jamadermatol.2021.2191"},{"key":"72293","doi-asserted-by":"crossref","unstructured":"Vose J, Armitage J, Weisenburger D; International T-Cell Lymphoma Project. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008; 26(25):4124-4130.","DOI":"10.1200\/JCO.2008.16.4558"},{"key":"72294","doi-asserted-by":"crossref","unstructured":"Zain JM, Hanona P. Aggressive T-cell lymphomas: 2021 updates on diagnosis, risk stratification and management. Am J Hematol. 2021; 96(8):1027-1046.","DOI":"10.1002\/ajh.26270"},{"key":"72295","doi-asserted-by":"crossref","unstructured":"Krangel MS. Mechanics of T cell receptor gene rearrangement. Curr Opin Immunol. 2009; 21(2):133-139.","DOI":"10.1016\/j.coi.2009.03.009"},{"key":"72296","doi-asserted-by":"crossref","unstructured":"Attygalle AD, Kyriakou C, Dupuis J. Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression. Am J Surg Pathol. 2007; 31(7):1077-1088.","DOI":"10.1097\/PAS.0b013e31802d68e9"},{"key":"72297","doi-asserted-by":"crossref","unstructured":"Chiba S, Sakata-Yanagimoto M. Advances in understanding of angioimmunoblastic T-cell lymphoma. Leukemia. 2020; 34(10):2592-2606.","DOI":"10.1038\/s41375-020-0990-y"},{"key":"72298","doi-asserted-by":"crossref","unstructured":"Grogg KL, Attygalle AD, Macon WR, Remstein ED, Kurtin PJ, Dogan A. Angioimmunoblastic T-cell lymphoma: a neoplasm of germinal-center T-helper cells?. Blood. 2005; 106(4):1501-1502.","DOI":"10.1182\/blood-2005-03-1083"},{"key":"72299","doi-asserted-by":"crossref","unstructured":"Yao WQ, Wu F, Zhang W. Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell. J Pathol. 2020; 250(3):346-357.","DOI":"10.1002\/path.5376"},{"key":"72300","doi-asserted-by":"crossref","unstructured":"Couronne L, Bastard C, Bernard OA. TET2 and DNMT3A mutations in human T-cell lymphoma. N Engl J Med. 2012; 366(1):95-96.","DOI":"10.1056\/NEJMc1111708"},{"key":"72301","doi-asserted-by":"crossref","unstructured":"Quivoron C, Couronne L, Della Valle V. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. Cancer Cell. 2011; 20(1):25-38.","DOI":"10.1016\/j.ccr.2011.06.003"},{"key":"72302","doi-asserted-by":"crossref","unstructured":"Zhang X, Su J, Jeong M. DNMT3A and TET2 compete and cooperate to repress lineage-specific transcription factors in hematopoietic stem cells. Nat Genet. 2016; 48(9):1014-1023.","DOI":"10.1038\/ng.3610"},{"key":"72303","doi-asserted-by":"crossref","unstructured":"Cheng S, Zhang W, Inghirami G, Tam W. Mutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking. Elife. 2021; 10:e66395.","DOI":"10.7554\/eLife.66395"},{"key":"72304","doi-asserted-by":"crossref","unstructured":"Sandell RF, Boddicker RL, Feldman AL. Genetic landscape and classification of peripheral T cell lymphomas. Curr Oncol Rep. 2017; 19(4):28.","DOI":"10.1007\/s11912-017-0582-9"},{"key":"72305","doi-asserted-by":"crossref","unstructured":"Vega F, Amador C, Chadburn A. Genetic profiling and biomarkers in peripheral T-cell lymphomas: current role in the diagnostic work-up. Mod Pathol. 2022; 35(3):306-318.","DOI":"10.1038\/s41379-021-00937-0"},{"key":"72306","doi-asserted-by":"crossref","unstructured":"Schultheiss C, Simnica D, Willscher E. Next-generation immunosequencing reveals pathological T-cell architecture in autoimmune hepatitis. Hepatology. 2021; 73(4):1436-1448.","DOI":"10.1002\/hep.31473"},{"key":"72307","doi-asserted-by":"crossref","unstructured":"Simnica D, Akyuz N, Schliffke S. T cell receptor next-generation sequencing reveals cancer-associated repertoire metrics and reconstitution after chemotherapy in patients with hematological and solid tumors. Oncoimmunology. 2019; 8(11):e1644110.","DOI":"10.1080\/2162402X.2019.1644110"},{"key":"72308","doi-asserted-by":"crossref","unstructured":"Simnica D, Schliffke S, Schultheiss C. High-throughput immunogenetics reveals a lack of physiological T cell clusters in patients with autoimmune cytopenias. Front Immunol. 2019; 10:1897.","DOI":"10.3389\/fimmu.2019.01897"},{"key":"72309","doi-asserted-by":"crossref","unstructured":"Bolotin DA, Poslavsky S, Mitrophanov I. MiXCR: software for comprehensive adaptive immunity profiling. Nat Methods. 2015; 12(5):380-381.","DOI":"10.1038\/nmeth.3364"},{"key":"72310","doi-asserted-by":"crossref","unstructured":"Schultheiss C, Paschold L, Simnica D. Next-generation sequencing of T and B cell receptor repertoires from COVID-19 patients showed signatures associated with severity of disease. Immunity. 2020; 53(2):442-455.","DOI":"10.1016\/j.immuni.2020.06.024"},{"key":"72311","doi-asserted-by":"crossref","unstructured":"Schumann FL, Gross E, Bauer M. Divergent effects of EZH1 and EZH2 protein expression on the prognosis of patients with T-cell lymphomas. Biomedicines. 2021; 9(12):1842.","DOI":"10.3390\/biomedicines9121842"},{"key":"72312","doi-asserted-by":"crossref","unstructured":"Meyer-Olson D, Simons BC, Conrad JA. Clonal expansion and TCR-independent differentiation shape the HIV-specific CD8+ effector-memory T-cell repertoire in vivo. Blood. 2010; 116(3):396-405.","DOI":"10.1182\/blood-2009-11-254136"},{"key":"72313","doi-asserted-by":"crossref","unstructured":"Ciupe SM, Devlin BH, Markert ML, Kepler TB. Quantification of total T-cell receptor diversity by flow cytometry and spectratyping. BMC Immunol. 2013; 14:35.","DOI":"10.1186\/1471-2172-14-35"},{"key":"72314","doi-asserted-by":"crossref","unstructured":"Ren J, Liao X, Lewis JM. Generation and optimization of off-the-shelf immunotherapeutics targeting TCR-Vbeta2+ T cell malignancy. Nat Commun. 2024; 15(1):519.","DOI":"10.1038\/s41467-024-44786-2"},{"key":"72315","doi-asserted-by":"crossref","unstructured":"Bauer M, Vaxevanis C, Bethmann D. Multiplex immunohistochemistry as a novel tool for the topographic assessment of the bone marrow stem cell niche. Methods Enzymol. 2020; 635:67-79.","DOI":"10.1016\/bs.mie.2019.05.055"},{"key":"72316","doi-asserted-by":"crossref","unstructured":"Schultheiss C, Paschold L, Willscher E. Maturation trajectories and transcriptional landscape of plasmablasts and autoreactive B cells in COVID-19. iScience. 2021; 24(11):103325.","DOI":"10.1016\/j.isci.2021.103325"},{"key":"72317","doi-asserted-by":"crossref","unstructured":"Wang P, Jin X, Zhou W. Comprehensive analysis of TCR repertoire in COVID-19 using single cell sequencing. Genomics. 2021; 113(2):456-462.","DOI":"10.1016\/j.ygeno.2020.12.036"},{"key":"72318","doi-asserted-by":"crossref","unstructured":"Herrera A, Cheng A, Mimitou EP. Multimodal single-cell analysis of cutaneous T-cell lymphoma reveals distinct subclonal tissue-dependent signatures. Blood. 2021; 138(16):1456-1464.","DOI":"10.1182\/blood.2020009346"},{"key":"72319","unstructured":"x Genomics. Integrated GEX and VDJ analysis of Connect generated library from human PBMCs by Cell Ranger 6.0.1. 2021. Publisher Full Text|"},{"key":"72320","doi-asserted-by":"crossref","unstructured":"Willinger T, Freeman T, Herbert M, Hasegawa H, McMichael AJ, Callan MF. Human naive CD8 T cells down-regulate expression of the WNT pathway transcription factors lymphoid enhancer binding factor 1 and transcription factor 7 (T cell factor-1) following antigen encounter in vitro and in vivo. J Immunol. 2006; 176(3):1439-1446.","DOI":"10.4049\/jimmunol.176.3.1439"},{"key":"72321","doi-asserted-by":"crossref","unstructured":"Vinuesa CG, Linterman MA, Yu D, MacLennan IC. Follicular helper T cells. Annu Rev Immunol. 2016; 34:335-368.","DOI":"10.1146\/annurev-immunol-041015-055605"},{"key":"72322","doi-asserted-by":"crossref","unstructured":"Choi YS, Gullicksrud JA, Xing S. LEF-1 and TCF-1 orchestrate T(FH) differentiation by regulating differentiation circuits upstream of the transcriptional repressor Bcl6. Nat Immunol. 2015; 16(9):980-990.","DOI":"10.1038\/ni.3226"},{"key":"72323","doi-asserted-by":"crossref","unstructured":"Pasquale EB. Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat Rev Cancer. 2010; 10(3):165-180.","DOI":"10.1038\/nrc2806"},{"key":"72324","doi-asserted-by":"crossref","unstructured":"Mehta A, Ratre YK, Soni VK. Orchestral role of lipid metabolic reprogramming in T-cell malignancy. Front Oncol. 2023; 13:1122789.","DOI":"10.3389\/fonc.2023.1122789"},{"key":"72325","doi-asserted-by":"crossref","unstructured":"Salerno F, Freen-van Heeren JJ, Guislain A, Nicolet BP, Wolkers MC. Costimulation through TLR2 drives polyfunctional CD8(+) T cell responses. J Immunol. 2019; 202(3):714-723.","DOI":"10.4049\/jimmunol.1801026"},{"key":"72326","doi-asserted-by":"crossref","unstructured":"Morrison C, Baer MR, Zandberg DP, Kimball A, Davila E. Effects of Toll-like receptor signals in T-cell neoplasms. Future Oncol. 2011; 7(2):309-320.","DOI":"10.2217\/fon.10.185"},{"key":"72327","doi-asserted-by":"crossref","unstructured":"Heavican TB, Bouska A, Yu J. Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma. Blood. 2019; 133(15):1664-1676.","DOI":"10.1182\/blood-2018-09-872549"},{"key":"72328","doi-asserted-by":"crossref","unstructured":"Odejide O, Weigert O, Lane AA. A targeted mutational landscape of angioimmunoblastic T-cell lymphoma. Blood. 2014; 123(9):1293-1296.","DOI":"10.1182\/blood-2013-10-531509"},{"key":"72329","doi-asserted-by":"crossref","unstructured":"Watatani Y, Sato Y, Miyoshi H. Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling. Leukemia. 2019; 33(12):2867-2883.","DOI":"10.1038\/s41375-019-0473-1"},{"key":"72330","doi-asserted-by":"crossref","unstructured":"Rodriguez M, Alonso-Alonso R, Tomas-Roca L. Peripheral T-cell lymphoma: molecular profiling recognizes subclasses and identifies prognostic markers. Blood Adv. 2021; 5(24):5588-5598.","DOI":"10.1182\/bloodadvances.2021005171"},{"key":"72331","doi-asserted-by":"crossref","unstructured":"Leca J, Lemonnier F, Meydan C. IDH2 and TET2 mutations synergize to modulate T follicular helper cell functional interaction with the AITL microenvironment. Cancer Cell. 2023; 41(2):323-339.","DOI":"10.1016\/j.ccell.2023.01.003"},{"key":"72332","doi-asserted-by":"crossref","unstructured":"Sakata-Yanagimoto M, Enami T, Yoshida K. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nat Genet. 2014; 46(2):171-175.","DOI":"10.1038\/ng.2872"},{"key":"72333","doi-asserted-by":"crossref","unstructured":"Harro CM, Sprenger KB, Chaurio RA. Sezary syndrome originates from heavily mutated hematopoietic progenitors. Blood Adv. 2023; 7(18):5586-5602.","DOI":"10.1182\/bloodadvances.2022008562"},{"key":"72334","doi-asserted-by":"crossref","unstructured":"Keats JJ, Chesi M, Egan JB. Clonal competition with alternating dominance in multiple myeloma. Blood. 2012; 120(5):1067-1076.","DOI":"10.1182\/blood-2012-01-405985"},{"key":"72335","doi-asserted-by":"crossref","unstructured":"Clemente MJ, Wlodarski MW, Makishima H. Clonal drift demonstrates unexpected dynamics of the T-cell repertoire in T-large granular lymphocyte leukemia. Blood. 2011; 118(16):4384-4393.","DOI":"10.1182\/blood-2011-02-338517"},{"key":"72336","doi-asserted-by":"crossref","unstructured":"To V, Evtimov VJ, Jenkin G, Pupovac A, Trounson AO, Boyd RL. CAR-T cell development for cutaneous T cell lymphoma: current limitations and potential treatment strategies. Front Immunol. 2022; 13:968395.","DOI":"10.3389\/fimmu.2022.968395"},{"key":"72337","doi-asserted-by":"crossref","unstructured":"Oh BLZ, Vinanica N, Wong DMH, Campana D. Chimeric antigen receptor T-cell therapy for T-cell acute lymphoblastic leukemia. Haematologica. 2024; 109(6):1677-1688.","DOI":"10.3324\/haematol.2023.283848"},{"key":"72338","doi-asserted-by":"crossref","unstructured":"Paul S, Pearlman AH, Douglass J. TCR beta chain-directed bispecific antibodies for the treatment of T cell cancers. Sci Transl Med. 2021; 13(584):eabd3595.","DOI":"10.1126\/scitranslmed.abd3595"},{"key":"72339","doi-asserted-by":"crossref","unstructured":"Suma S, Suehara Y, Fujisawa M. Tumor heterogeneity and immune-evasive T follicular cell lymphoma phenotypes at single-cell resolution. Leukemia. 2024; 38(2):340-350.","DOI":"10.1038\/s41375-023-02093-7"},{"key":"72340","doi-asserted-by":"crossref","unstructured":"Zhu Q, Yang Y, Deng X. High CD8(+) tumor-infiltrating lymphocytes indicate severe exhaustion and poor prognosis in angioimmunoblastic T-cell lymphoma. Front Immunol. 2023; 14:1228004.","DOI":"10.3389\/fimmu.2023.1228004"},{"key":"72341","doi-asserted-by":"crossref","unstructured":"Liu X, Jin S, Hu S. Single-cell transcriptomics links malignant T cells to the tumor immune landscape in cutaneous T cell lymphoma. Nat Commun. 2022; 13(1):1158.","DOI":"10.1038\/s41467-022-28799-3"},{"key":"72342","doi-asserted-by":"crossref","unstructured":"Iyer A, Hennessey D, O\u2019Keefe S. Clonotypic heterogeneity in cutaneous T-cell lymphoma (mycosis fungoides) revealed by comprehensive whole-exome sequencing. Blood Adv. 2019; 3(7):1175-1184.","DOI":"10.1182\/bloodadvances.2018027482"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2024.285395\/77481","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2024.285395\/78039","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11739\/77481","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:07:13Z","timestamp":1794046033000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2024.285395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,29]]},"references-count":65,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2024.285395","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,29]]}}}